BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2000
View Archived Issues
Alkermes and Glaxo Wellcome finalize pulmonary drug delivery agreement
Read More
Antex traveler's diarrhea vaccine awarded funding from U.S Army
Read More
PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis
Read More
BTG obtains rights for a novel approach to treat malaria
Read More
Genzyme General and Genzyme Tissue Repair extend NeuroCell-PD milestone deadline
Read More
BioChem Pharma sells share of North American Vaccine
Read More
Aviron initiates clinical testing of CMV vaccine
Read More
Positive preliminary phase I/II results of HCT-1026 in contact urticaria
Read More
Argatroban approved for HIT in U.S.
Read More
Systemically administered caspase inhibitor provides neuroprotection in rat model
Read More
Aventis and NPS Allelix join together to develop novel, selective dopamine D4 antagonists
Read More
Novel NK1 receptor antagonists: synthesis and SAR presented by Merck in Kansas City
Read More
New human prolactin receptor antagonist S179D-PRL undergoes extensive biological testing
Read More
NC-2100: a new thiazolidinedione with a unique pharmacological profile
Read More
Organon's Orgalutran approved in E.U. for treatment of infertility
Read More
Elaidic acid ester of ganciclovir as a promising new Rx for herpesvirus infections
Read More
Prolifix enters agreement for cell cycle protein research
Read More
Synthetic conjugated oral estrogen holds significant promise as HRT for postmenopausal women
Read More
Agenerase receives positive opinion from CPMP
Read More
Topiramate now claimed effective in schizophrenia
Read More
Ferrer's new antihypertensive angiotensin II antagonists prove more potent than losartan
Read More
Dual estrogen agonist/antagonist compounds and their use revealed by Akzo Nobel
Read More
Potent HCV NS3 protease inhibitors designed at Italian laboratory
Read More
Potential new treatments for asthma from Roche act as chemokine receptor antagonists
Read More
Peptides useful in toxic shock syndrome discovered by Rockefeller U. researchers
Read More
Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes
Read More
Patent issued to Meiji Seika covering benzoxazole derivatives and use for treating GI disorders
Read More
Naphthalene compounds from Torii promote fibrinolysis and exert antithrombotic activity
Read More
Biomira acquires remaining rights to Theratope from Chiron
Read More